C82.69 Cutaneous follicle center lymphoma, extranodal and solid organ sites

Name of the Condition

• Cutaneous Follicle Center Lymphoma, Extranodal and Solid Organ Sites

Summary

Cutaneous follicle center lymphoma is a type of non-Hodgkin lymphoma that originates in the skin, specifically affecting B-cells. It is characterized by the slow growth of cancerous lymphocytes, which can form nodules or plaques in the skin. When involving extranodal and solid organ sites, the condition may present with lesions or involvement beyond typical cutaneous locations, such as in organs or tissues outside the lymph nodes. This condition is typically indolent but may progress over time.

Causes

The exact cause of cutaneous follicle center lymphoma is not fully understood, but it is associated with genetic mutations in B-cells. Environmental factors and immune system dysfunction may contribute to its development.

Risk Factors

• Age: More common in individuals over 60.
• Family history: A history of lymphoma can increase risk.
• Immune system deficiencies.
• Certain infections, such as hepatitis C.

Symptoms

• Painless skin nodules or plaques.
• Red or purple lesions.
• Lesions that may be localized or widespread.
• Pruritus (itching) in some cases.
• Possible involvement of extranodal sites or solid organs, which may present with organ-specific symptoms.

Diagnosis

Diagnosis involves a physical examination, medical history review, skin biopsy to confirm the presence of lymphoma, and possibly imaging studies to assess for systemic involvement. Additional tests may be required to evaluate extranodal or solid organ involvement.

Treatment Options

• Watchful waiting: Monitoring the condition without immediate treatment if symptoms are mild.
• Topical therapies: Creams or ointments applied to the skin.
• Radiation therapy: Targeted treatment for localized lesions.
• Systemic therapies: Chemotherapy or immunotherapy for widespread or extranodal involvement.
• Surgery: Removal of isolated lesions or affected tissue.

Prognosis and Follow-Up

Prognosis depends on the extent of disease, including involvement of extranodal or solid organ sites. Regular follow-up is essential to monitor for progression or recurrence. Treatment may be adjusted based on response and disease status.

Complications

• Progression to more aggressive lymphoma.
• Involvement of multiple extranodal sites or organs.
• Skin infections due to lesions.
• Psychological impact from visible skin changes.

Lifestyle & Prevention

• Protect skin from excessive sun exposure.
• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known triggers or irritants that may exacerbate skin lesions.
• Seek prompt medical attention for new or changing skin lesions.

When to Seek Professional Help

• New or worsening skin lesions.
• Unexplained swelling or pain in organs or tissues.
• Persistent itching or discomfort.
• Signs of infection, such as redness, warmth, or pus.

Tips for Medical Coders

When coding for cutaneous follicle center lymphoma involving extranodal and solid organ sites, ensure documentation specifies the affected sites (e.g., lung, liver, or other organs) to support the use of code C82.69. Verify that the diagnosis aligns with the clinical presentation and that any relevant biopsy or imaging results are documented to confirm extranodal involvement.